Extracellular signal-regulated kinase activates topoisomerase IIα, through a mechanism independent of phosphorylation

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3551-3560

  Shapiro, Paul S ^a   Whalen, Anne M ^a   Tolwinski, Nicholas S ^a   Wilsbacher, Julie ^b   Froelich Ammon, Stacie J ^a   Garcia, Marileila ^c   Osheroff, Neil ^d   Ahn, Natalie G ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CHROMATIN STRUCTURE; CHROMOSOME CONDENSATION; CHROMOSOME SEGREGATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032961902     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.5.3551     Document Type: Article

References (60)

1. Ackerman, P., C. V. C. Glover, and N. Osheroff. 1985. Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro. Proc. Natl. Acad. Sci. USA 82:3164-3168.
2. 2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure. J. Cell Biol. 136:29-43.
3. 3-stimulated Egr induction. J. Biol. Chem. 270:3642-3647.
4. Bojanowski, K., O. Filhol, C. Cochet, E. M. Chambaz, and A. K. Larsen. 1993. DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active. J. Biol. Chem. 268:22920-22926.
5. Brunet, A., G. Pagès, and J. Pouysségur. 1994. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9:3379-3387.
6. Burden, D. A., and D. M. Sullivan. 1994. Phosphorylation of the α- and β-isoforms of DNA topoisomerase II is qualitatively different in interphase and mitosis in Chinese hamster ovary cells. Biochemistry 33:14651-14655.
7. Burden, D. A., and N. Osherhoff. 1998. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400:139-154.
8. Cardenas, M. E., Q. Dang, C. V. C. Glover, and S. M. Gasser. 1992. Casein kinase II phosphorylates the eukaryote-specific C-terminal domain of topoisomerase II in vivo. EMBO J. 11:1785-1796.
9. Corbett, A. H., R. F. DeVore, and N. Osheroff. 1992. Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. J. Biol. Chem. 267:20513-20518.
10. Corbett, A. H., A. W. Fernald, and N. Osheroff. 1993. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation. Biochemistry 32:2090-2097.
11. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
12. Denko, N. C., A. J. Giaccia, J. R. Stringer, and P. J. Stambrook. 1994. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc. Natl. Acad. Sci. USA 91:5124-5128.
13. DeVore, R. F., A. H. Corbett, and N. Osheroff. 1992. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4′-(9′-acridinylamino)methane-sulfon-m-anisidide. Cancer Res. 52:2156-2161.
14. DiNardo, S., K. Voelkel, and R. Sternglanz. 1984. DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. USA 81:2616-2620.
15. 2 cycle checkpoint in mammalian cells. Nature 372:467-470.
16. Earnshaw, W. C., and A. M. MacKay. 1994. Role of nonhistone proteins in the chromosomal events of mitosis. FASEB J. 8:947-956.
17. Englund, P. T. 1978. The replication of kinetoplast DNA networks in Crithidia fasciculata. Cell 14:157-168.
18. Froelich-Ammon, S. J., and N. Osheroff. 1995. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270:21429-21432.
19. Fukasawa, K., and G. F. Vande Woude. 1997. Synergy between the Mos/ mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol. Cell. Biol. 17:506-518.
20. Heck, M. M. S., W. N. Hittelman, and W. C. Earnshaw. 1989. In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. J. Biol. Chem. 264:15161-15164.
21. Isaacs, R. J., S. L. Davies, M. I. Sandri, C. Redwood, N. J. Wells, and I. D. Hickson. 1998. Physiological regulation of eukaryotic topoisomerase II. Biochim. Biophys. Acta 1400:121-137.
22. Ishida, R., M. Hamatake, R. A. Wasserman, J. L. Nitiss, J. C. Wang, and T. Andoh. 1995. DNA topoisomerase II is a molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Cancer Res. 55:2299-2303.
23. Khokhlatchev, A. V., B. Canagarajah, J. Wilsbacher, M. Robinson, M. Alkinson, E. Goldsmith, and M. H. Cobb. 1998. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605-615.
24. Khosravi-Far, R., P. A. Solski, G. J. Clark, M. S. Kinch, and C. J. Der. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:6443-6453.
25. Kimura, K., M. Saijo, M. Ui, and T. Enomoto. 1994. Identification of the nature of modification that causes the shift of DNA topoisomerase IIβ to apparent higher molecular weight forms in the M phase. J. Biol. Chem. 269:24523-24526.
26. Kimura, K., M. Saijo, M. Tanaka, and T. Enomoto. 1996. Phosphorylation-independent stimulation of DNA topoisomerase IIα activity. J. Biol. Chem. 271:10990-10995.
27. Kimura, K., N. Nozaki, T. Enomoto, M. Tanaka, and A. Kikuchi. 1996. Analysis of M phase-specific phosphorylation of DNA topoisomerase II. J. Biol. Chem. 271:21439-21445.
28. Kingma, P. S., C. A. Greider, and N. Osheroff. 1997. Spontaneous DNA lesions poison human topoisomerase IIα and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry 36:5934-5939.
29. Koo, H.-M., A. Monks, A. Mikheev, L. V. Rubinstein, M. Gray-Goodrich, M. J. McWilliams, W. G. Alvord, H. K. Oie, A. F. Gazdar, K. D. Paull, H. Zarbl, and G. F. Vande Woude. 1996. Enhanced sensitivity to 1-β-D-arabinosfuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res. 56:5211-5216.
30. Kortenjann, M., O. Thomae, and P. E. Shaw. 1994. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol. Cell. Biol. 14:4815-4824.
31. mapk pathway. J. Biol. Chem. 271:20608-20616.
32. Lenormand, P., J. M. Brondello, A. Brunet, and J. Pouyssegur. 1998. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell Biol. 142:625-633.
33. Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49-139.
34. Luke, M., and D. F. Bogenhagen. 1989. Quantitation of type II topoisomerase in oocytes and eggs of Xenopus laevis. Dev. Biol. 136:459-468.
35. Mansour, S. J., J. M. Candia, J. E. Matsuura, M. C. Manning, and N. G. Ahn. 1996. Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1. Biochemistry 35:15529-15536.
36. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970.
37. Mansour, S. J., K. A. Resing, J. M. Candia, A. S. Hermann, J. W. Gloor, K. R. Herskind, M. Wartmann, R. J. Davis, and N. G. Ahn. 1994. Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis. J. Biochem. 116:304-314.
38. Meyer, K. N., E. Kjelden, T. Straub, B. R. Knudsen, I. D. Hickson, A. Kikuchi, H. Kreipe, and F. Boege. 1997. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136:755-788.
39. Nitiss, J. L. 1998. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta 1400:63-81.
40. Osheroff, N., E. R. Shelton, and D. L. Brutlag. 1983. DNA topoisomerase II from Drosophila melanogaster. J. Biol. Chem. 258:9536-9543.
41. Qiu, R. G., J. Chen, D. Kirn, F. McCormick, and M. Symons. 1995. An essential role for Rac in Ras transformation. Nature 374:457-459.
42. Rattner, J. B., M. J. Hendzel, C. S. Furbee, M. T. Muller, and D. P. Bazett-Jones. 1996. Topoisomerase IIα is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell Biol. 134:1097-1107.
43. Redwood, C., S. L. Davies, N. J. Wells, A. M. Fry, and I. D. Hickson. 1998. Casein kinase II stabilizes the activity of human topoisomerase IIα in a phosphorylation-independent manner. J. Biol. Chem. 273:3635-3642.
44. Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytokeleton by ras. Cell 89:457-467.
45. Sahyoun, N., M. Wolf, J. Besterman, T.-S. Hsieh, M. Sander, H. LeVine III, K.-J. Chang, and P. Cuatrecasas. 1986. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc. Natl. Acad. Sci. USA 83:1603-1607.
46. Saijo, M., M. Ui, and T. Enomoto. 1992. Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells. Biochemistry 31:359-363.
47. Saitoh, Y., and U. K. Laemmli. 1994. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76:509-622.
48. Shapiro, P. S., E. Vaisberg, A. J. Hunt, N. S. Tolwinski, A. M. Whalen, J. R. McIntosh, and N. G. Ahn. 1998. Activation of the MKK/ERK pathway during somatic cell mitosis. Direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen. J. Cell Biol. 142:1533-1545.
49. Shelton, E. R., N. Osheroff, and D. L. Brutlag. 1983. DNA topoisomerase II from Drosophila melanogaster. J. Biol. Chem. 258:9530-9535.
50. Sif, S., P. T. Stukenberg, M. W. Kirschner, and R. E. Kingston. 1998. Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev. 12:2842-2851.
51. Taagepera, S., P. N. Rao, F. H. Drake, and G. J. Gorbsky. 1993. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl. Acad. Sci. USA 90: 8407-8411.
52. Traverse, S., N. Gomez, H. Paterson, C. Marshall, and P. Cohen. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:351-355.
53. Vassetzky, Y. S., Q. Dang, P. Benedetti, and S. M. Gasser. 1994. Topoisomerase II forms multimers in vitro: effects of metals, β-glycerophosphate, and phosphorylation of its C-terminal domain. Mol. Cell. Biol. 14:6962-6974.
54. mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. Biochem. J. 289:209-214.
55. Wang, J. C. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65:635-692.
56. Wells, N. J., C. M. Addison, A. M. Fry, R. Ganapathi, and I. D. Hickson. 1994. Serine 1524 is a major site of phosphorylation on human topoisomerase IIα protein in vivo and is a substrate for casein kinase II in vitro. J. Biol. Chem. 269:29746-29751.
57. Wells, N. J., and I. D. Hickson. 1995. Human topoisomerase IIα is phosphorylated in a cell-cycle phase-dependent manner by a proline-directed kinase. Eur. J. Biochem. 231:491-497.
58. Whalen, A. M., S. C. Galasinski, P. S. Shapiro, T. S. Nahreini, and N. G. Ahn. 1997. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell Biol. 17:1947-1958.
59. Wright, J. H., E. Munar, P. Andreassen, R. Margolis, R. Seger, and E. G. Krebs. Unpublished data.
60. Zecevic, M., A. D. Catling, S. T. Eblen, L. Renzi, J. C. Hittle, T. J. Yen, G. J. Gorbsky, and M. J. Weber. 1998. Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E. J. Cell Biol. 142:1547-1558.